|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/28 | |||
| A61K 31/381 | |||
| A61P 3/10 | |||
| A61P 3/04 | |||
| A61P 3/06 | |||
| A61P 9/12 | |||
| A61P 9/10 | |||
| A61K 31/7034 | |||
| A61K 31/7042 | |||
| A61P 3/08 | |||
| A61P 13/12 | |||
| A61P 17/02 | |||
| A61P 25/00 | |||
| A61P 27/02 |
| (11) | Number of the document | 2568971 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11725825.1 |
| Date of filing the European patent application | 2011-05-11 | |
| (97) | Date of publication of the European application | 2013-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2011/061354 |
| Date | 2011-05-11 |
| (87) | Number | WO 2011/142478 |
| Date | 2011-11-17 |
| (30) | Number | Date | Country code |
| 333312 P | 2010-05-11 | US |
| (72) |
SUGIMOTO Masaaki, JP
KINOSHITA Hajime, JP
TOKUDA Takayuki, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505,
JP
|
| (54) | CANAGLIFLOZIN CONTAINING TABLETS |
| CANAGLIFLOZIN CONTAINING TABLETS |